Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines
- PMID: 32150612
- PMCID: PMC7065473
- DOI: 10.1182/bloodadvances.2019000462
Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines
Erratum in
-
Etxeandia-Ikobaltzeta I, Zhang Y, Brundisini F, et al. Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines. Blood Adv. 2020;4(5):953-968.Blood Adv. 2020 Apr 14;4(7):1219. doi: 10.1182/bloodadvances.2020001861. Blood Adv. 2020. PMID: 32227209 Free PMC article. No abstract available.
Abstract
Values and preferences relate to the importance that patients place on health outcomes (eg, bleeding, having a deep venous thrombosis) and are essential when weighing benefits and harms in guideline recommendations. To inform the American Society of Hematology guidelines for management of venous thromboembolism (VTE) disease, we conducted a systematic review of patients' values and preferences related to VTE. We searched Medline, Embase, Cochrane Central Register of Controlled Trials, PsycINFO, and the Cumulative Index to Nursing and Allied Health Literature from inception to April of 2018 (PROSPERO-CRD42018094003). We included quantitative and qualitative studies. We followed Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidance for rating the certainty and presenting findings for quantitative research about the relative importance of health outcomes and a grounded theory approach for qualitative thematic synthesis. We identified 14 quantitative studies (2465 participants) describing the relative importance of VTE-related health states in a widely diverse population of patients, showing overall small to important impact on patients' lives (certainty of the evidence from low to moderate). Additionally, evidence from 34 quantitative studies (6424 participants) and 15 qualitative studies (570 participants) revealed that patients put higher value on VTE risk reduction than on the potential harms of the treatment (certainty of evidence from low to moderate). Studies also suggested a clear preference for oral medication over subcutaneous medication (moderate certainty). The observed variability in health state values may be a result of differences in the approaches used to elicit them and the diversity of included populations rather than true variability in values. This finding highlights the necessity to explore the variability induced by different approaches to ascertain values.
© 2020 by The American Society of Hematology.
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Figures


Similar articles
-
Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.Cochrane Database Syst Rev. 2020 Oct 10;10(10):CD013399. doi: 10.1002/14651858.CD013399.pub2. Cochrane Database Syst Rev. 2020. PMID: 33038027 Free PMC article.
-
American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.Blood Adv. 2018 Nov 27;2(22):3317-3359. doi: 10.1182/bloodadvances.2018024802. Blood Adv. 2018. PMID: 30482767 Free PMC article.
-
Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery.J Thorac Cardiovasc Surg. 2023 Mar;165(3):794-824.e6. doi: 10.1016/j.jtcvs.2022.05.041. Epub 2022 Dec 15. J Thorac Cardiovasc Surg. 2023. PMID: 36895083
-
Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery.Eur J Cardiothorac Surg. 2022 Dec 2;63(1):ezac488. doi: 10.1093/ejcts/ezac488. Eur J Cardiothorac Surg. 2022. PMID: 36519935
-
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.Cochrane Database Syst Rev. 2020 May 6;5(5):CD005259. doi: 10.1002/14651858.CD005259.pub4. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2022 Aug 22;8:CD005259. doi: 10.1002/14651858.CD005259.pub5. PMID: 32374919 Free PMC article. Updated.
Cited by
-
Values and preferences towards the use of prophylactic low-molecular-weight heparin during pregnancy: a convergent mixed-methods secondary analysis of data from the decision analysis in shared decision making for thromboprophylaxis during pregnancy (DASH-TOP) study.Thromb J. 2024 Sep 6;22(1):81. doi: 10.1186/s12959-024-00648-x. Thromb J. 2024. PMID: 39243049 Free PMC article.
-
Eight Ways General Internists Can Practice High-Value, Low-Carbon Care: The Canadian Society of Internal Medicine's Climate Conscious Choosing Wisely Canada Recommendations.J Gen Intern Med. 2025 May;40(7):1609-1616. doi: 10.1007/s11606-025-09441-6. Epub 2025 Feb 27. J Gen Intern Med. 2025. PMID: 40016377
-
Using Explicit Thresholds were valuable for judging Benefits and Harms in partially contextualized GRADE Guidelines.J Clin Epidemiol. 2022 Jul;147:69-75. doi: 10.1016/j.jclinepi.2022.03.017. Epub 2022 Mar 30. J Clin Epidemiol. 2022. PMID: 35364230 Free PMC article.
-
Direct-Acting Oral Anticoagulant Therapy in Cancer Patients-A Review.Cancers (Basel). 2023 May 10;15(10):2697. doi: 10.3390/cancers15102697. Cancers (Basel). 2023. PMID: 37345034 Free PMC article. Review.
-
Anticoagulation at the end of life: whether, when, and how to treat.Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):348-354. doi: 10.1182/hematology.2024000559. Hematology Am Soc Hematol Educ Program. 2024. PMID: 39644066 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous